PT1297342E - Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii - Google Patents

Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii

Info

Publication number
PT1297342E
PT1297342E PT01931928T PT01931928T PT1297342E PT 1297342 E PT1297342 E PT 1297342E PT 01931928 T PT01931928 T PT 01931928T PT 01931928 T PT01931928 T PT 01931928T PT 1297342 E PT1297342 E PT 1297342E
Authority
PT
Portugal
Prior art keywords
holo
alzheimer
transcobalamin
diagnosis
disease based
Prior art date
Application number
PT01931928T
Other languages
English (en)
Inventor
Orning Lars
Original Assignee
Axis Shield Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axis Shield Asa filed Critical Axis Shield Asa
Publication of PT1297342E publication Critical patent/PT1297342E/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
PT01931928T 2000-07-04 2001-05-22 Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii PT1297342E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016460.8A GB0016460D0 (en) 2000-07-04 2000-07-04 Assay

Publications (1)

Publication Number Publication Date
PT1297342E true PT1297342E (pt) 2005-10-31

Family

ID=9895035

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01931928T PT1297342E (pt) 2000-07-04 2001-05-22 Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii

Country Status (11)

Country Link
US (1) US7294514B2 (pt)
EP (1) EP1297342B1 (pt)
JP (1) JP2004502940A (pt)
AT (1) ATE302416T1 (pt)
AU (1) AU2001258614A1 (pt)
DE (1) DE60112758T2 (pt)
DK (1) DK1297342T3 (pt)
ES (1) ES2249432T3 (pt)
GB (1) GB0016460D0 (pt)
PT (1) PT1297342E (pt)
WO (1) WO2002003074A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150065449A1 (en) 2011-08-12 2015-03-05 Florida State University Research Foundation, Inc. Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG
CN110381935A (zh) * 2017-04-11 2019-10-25 雀巢产品有限公司 用于识别和减轻个体的认知衰老的ω-3脂肪酸和维生素D水平
WO2018188771A1 (en) * 2017-04-11 2018-10-18 Nestec S.A. Omega-3 fatty acid and vitamin d levels to identify and attenuate cognitive aging in individuals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273757A (en) * 1977-06-02 1981-06-16 Yissum Research Development Company Determination of transcobalamins
US4680273A (en) * 1985-07-29 1987-07-14 Victor Herbert Assay for vitamin B12 deficiency
AU5436499A (en) * 1998-08-20 2000-03-14 Axis Biochemicals Asa Assay method for cardiovascular disease
GB9820473D0 (en) 1998-09-18 1998-11-11 Axis Biochemicals Asa Assay

Also Published As

Publication number Publication date
ES2249432T3 (es) 2006-04-01
DK1297342T3 (da) 2005-12-19
JP2004502940A (ja) 2004-01-29
US20040014230A1 (en) 2004-01-22
EP1297342A1 (en) 2003-04-02
WO2002003074A1 (en) 2002-01-10
DE60112758T2 (de) 2006-06-29
EP1297342B1 (en) 2005-08-17
ATE302416T1 (de) 2005-09-15
GB0016460D0 (en) 2000-08-23
DE60112758D1 (de) 2005-09-22
US7294514B2 (en) 2007-11-13
AU2001258614A1 (en) 2002-01-14

Similar Documents

Publication Publication Date Title
DE69928809D1 (de) Differentielle diagnose von neurodegeneration
GB0510943D0 (en) Improved immunoassay methods
BR0206604A (pt) Dispositivo de lanceta que tem ação capilar
DE60016178D1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
DK1381866T3 (da) Fremgangsmåde til differentialdiagnosticering af Alzheimers demens samt anordning hertil
WO2007016367A3 (en) Neoplastic disease-related methods, kits, systems and databases
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
EP2251695A3 (en) Markers associated with endometrial disease
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
PT1297342E (pt) Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii
ATE420365T1 (de) Präparierung von sphären für diagnostische tests
BR9913770A (pt) Processo de ensaio para determinação da cobalamina ligada a transcobalamina ii (tcii) em uma amostra de corpo, kit para uso em um ensaio diagnóstico, e, uso de holo-tc ii
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
BR0007702A (pt) Método e kit de diagnóstico para diagnose de endometriose
BRPI0415562A (pt) reagente para avaliação diagnóstica e/ou prognóstica de carcinoma, métodos para determinação de p-lap que é um fator prognóstico em carcinoma, e para avaliação prognóstica de carcinoma, e, kit de imunoensaio para determinação da quantidade de p-lap presente em tecidos de carcinoma
DE60235576D1 (de) Diagnostikum für die frühe phase von morbus alzheimer
WO2003104812A3 (en) DIAGNOSIS ASSAY FOR ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE HA DOLLAR G (B) 42 RATE: HA DOLLAR G (B) 40
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
ATE478147T1 (de) Aus einem neuroblastom isolierte nukleinsäuren
WO2003050541A3 (de) Diagnose der malaria durch bestimmung von autoantikörper gegen calreticulin
WO2002044723A3 (en) Method for diagnosing a predisposition of psychosis in a progeny